Technical Specifications

Sterile manufacturing tolerances and throughput capacity

Engineered for high-potency active pharmaceutical ingredients and rigorous aseptic fill-finish protocols under absolute containment.

18,000

units per hour max fill

OEB 5

containment threshold

72 hrs

analytical release time

Dedicated Suites

Three primary manufacturing environments

Suite Alpha

Aseptic Liquid Vials

Automated nested syringe and vial lines running at speeds up to 18,000 units per hour with continuous particle monitoring and restricted access barrier systems.

Suite Beta

Lyophilized Vials

Integrated automated loading and unloading freeze dryers with precise thermodynamic shelf control and automated CIP/SIP sterilization cycles.

Suite Gamma

High-Potency Solid Dosage

Rigid isolators and closed barrier systems capable of OEB 5 compounds under negative differential pressure for highly active compounds.

Methodology

The four-stage tech transfer protocol

01
02
03
04

Analytical Validation

Pilot Scale-Up

Media Fills

Commercial Release

Method transfer, HPLC method verification, and baseline impurity profiling against pharmacopeial standards.

Bridging laboratory scale parameters to full commercial batch equipment under strict parameter mapping.

Executing three consecutive successful aseptic simulation runs prior to clinical or commercial batch authorization.

In-house chromatographic and mass spectrometry testing delivering verified certificates of analysis within 72 hours.

Evaluate line availability and changeover schedules

Connect directly with our technical operations group to review batch slot allocations and facility master files.